

Increase speed to market
Octozi automates clinical development workflows, with Generative Artificial Intelligence (AI) and advanced machine learning analytics, accelerating your time to market.

Safety
Improve patient safety by AI driven early safety signal detection across data. Enable study teams to take faster corrective actions.
Data Management
Enable real-time detection of discrepancies in clinical data going beyond basic edit checks and noisy RBQM solutions
Clinical Science
Visualize and monitor clinical data for safety and efficacy.
Octozi's AI goes beyond edit checks and manual review to identify nuanced & critical risks in data

Designed from the ground-up with security as a pillar




Octozi's platform is built to ensure you are in compliance and ensure your data's privacy and security. These capabilities are built in at the design of our technology. Additionally, we are certified by multiple independent authorities to reinforce this commitment.
​
Octozi's robust accreditation and certification portfolio defines our industry’s gold standards around information security, patient data privacy, and compliance.
Industry leading security measures
Robust audit trails
Your data is never used to train models
Supported by leading organizations



Pioneers in AI for life sciences
Scalable, extensible platform
Platform built to handle the needs of biotech startups, large pharma, and CROs across Phase I - IV trials and a broad range of therapeutic areas
Powered by custom LLMs
Powered by custom developed large language models (LLMs) providing incredible performance.
Security and Privacy
Your data remains your data and is not shared or distributed to third parties.
Tuned for pharma
The only LLM-powered platform that's designed for clinical development
Why Octozi?
01 / QUALITY
Achieve higher quality. Reduce sources of errors and trial delays that can take your trial off course.
02 / TIME
Leverage AI to automate time consuming activities from months to a fraction of the time.
03 / COST
Reduce both direct and indirect costs associated with manual error prone activities.
​